Comparison of Riot Blockchain Inc. (RIOT) and Alder Biopharmaceuticals Inc. (NASDAQ:ALDR)

We will be comparing the differences between Riot Blockchain Inc. (NASDAQ:RIOT) and Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) as far as institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation are concerned. The two businesses are rivals in the Biotechnology industry.

Earnings and Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Riot Blockchain Inc. 6.36M 4.86 55.59M -2.81 0.00
Alder Biopharmaceuticals Inc. N/A 1016.14 304.82M -4.49 0.00

Table 1 highlights Riot Blockchain Inc. and Alder Biopharmaceuticals Inc.’s top-line revenue, earnings per share (EPS) and valuation.


Table 2 hightlights the net margins, return on assets and return on equity of the two companies.

Net Margins Return on Equity Return on Assets
Riot Blockchain Inc. -874.06% -225.6% -161.4%
Alder Biopharmaceuticals Inc. 0.00% -121.3% -62.6%

Risk and Volatility

Riot Blockchain Inc.’s 3.05 beta indicates that its volatility is 205.00% more volatile than that of Standard & Poor’s 500. In other hand, Alder Biopharmaceuticals Inc. has beta of 2.73 which is 173.00% more volatile than Standard & Poor’s 500.

Analyst Ratings

The table delivered features the ratings and recommendations for Riot Blockchain Inc. and Alder Biopharmaceuticals Inc.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Riot Blockchain Inc. 0 0 0 0.00
Alder Biopharmaceuticals Inc. 1 3 1 2.20

Competitively Alder Biopharmaceuticals Inc. has an average price target of $18, with potential upside of 29.31%.

Institutional & Insider Ownership

Roughly 9.8% of Riot Blockchain Inc. shares are owned by institutional investors while 0% of Alder Biopharmaceuticals Inc. are owned by institutional investors. 2.1% are Riot Blockchain Inc.’s share owned by insiders. Insiders Competitively, owned 0.4% of Alder Biopharmaceuticals Inc. shares.


Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Riot Blockchain Inc. -9.14% -41.72% -62.44% -77.28% -88.42% -94.05%
Alder Biopharmaceuticals Inc. -14.8% -21.86% -35.59% -30.7% 4.11% -0.44%

For the past year Riot Blockchain Inc. was more bearish than Alder Biopharmaceuticals Inc.


Alder Biopharmaceuticals Inc. beats on 7 of the 10 factors Riot Blockchain Inc.

Bioptix, Inc., through its subsidiary, BiOptix Diagnostics, Inc., develops enhanced surface plasmon resonance technology platform for the detection of molecular interactions. The company also focuses on animal healthcare and owns important intellectual property rights related to veterinary products. In addition, it has granted a license relating to single chain reproductive hormone technology for use in no-human mammals, which is under active development by the licensee bovine rFSH. The company was formerly known as Venaxis, Inc. and changed its name to Bioptix, Inc. in November 2016. Bioptix, Inc. was founded in 2000 and is based in Castle Rock, Colorado.

Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States, Australia, and Ireland. The companyÂ’s lead product candidate includes ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1910, a genetically engineered monoclonal antibody that is in preclinical study for the treatment of migraine; and Clazakizumab, an antibody, which has been completed Phase IIb clinical trial that inhibits the pro-inflammatory cytokine interleukin-6 for the treatment of rheumatoid and psoriatic arthritis. In addition, the company has preclinical programs in the discovery phase for various indications. Alder BioPharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.